ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER REGISTRY;
CANCER SURGERY;
CONTROLLED STUDY;
DATA BASE;
FEMALE;
HUMAN;
LARYNGECTOMY;
LARYNX CANCER;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL LITERATURE;
MULTIMODALITY CANCER THERAPY;
PUBLICATION;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC AGENTS;
CANCER CARE FACILITIES;
COMBINED MODALITY THERAPY;
FEMALE;
HOSPITALS, COMMUNITY;
HOSPITALS, TEACHING;
HUMANS;
LARYNGEAL NEOPLASMS;
LARYNGECTOMY;
MALE;
MEDICAL ONCOLOGY;
MIDDLE AGED;
UNITED STATES;
Larynx preservation in head and neck cancers. A discussion of the National Comprehensive Cancer Network Practice Guidelines
vi
Gillison M.L., and Forastiere A.A. Larynx preservation in head and neck cancers. A discussion of the National Comprehensive Cancer Network Practice Guidelines. Hematol Oncol Clin North Am 13 (1999) 699-718 vi
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group
Department of Veterans Affairs Laryngeal Cancer Study Group
Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324 (1991) 1685-1690
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
EORTC Head and Neck Cancer Cooperative Group
Lefebvre J.L., Chevalier D., Luboinski B., et al., EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88 (1996) 890-899
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098